Cronos Group Inc. (NASDAQ:CRON)
| Market Cap | $1.25B+34.3% |
| Revenue (ttm) | $205.57M+55.3% |
| Net Income | $57.63M+59.7% |
| EPS | $0.15+66.1% |
| Shares Out | 366.47M |
| PE Ratio | 21.17 |
| Forward PE | 18.53 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 938,479 |
| Open | $3.44 |
| Previous Close | $3.45 |
| Day's Range | $3.38 - $3.46 |
| 52-Week Range | $2.28 - $3.91 |
| Beta | 1.20 |
| Analysts | Hold |
| Price Target | $2.30(-32.55%) |
| Earnings Date | Feb 25, 2027 |
About CRON
Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.
Next catalysts
- Feb 25, 2027Earnings report
$CRON stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in CRON holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CRON's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CRON Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CRON Revenue by Segment or Geography
| Cannabis flower | $47.98M | 75.62% |
| Cannabis extracts | $15.46M | 24.36% |
| Other | $10.00K | 0.02% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New CRON patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CRON from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CRON
| VALTETFMG Sit Ultra Short ETF | $14.53M |
| SILXETFMG Prime 2x Daily Junior Silver Miners ETF | $13.38M |
| MJAmplify Alternative Harvest ETF | $12.02M |
| YOLOAdvisorShares Pure Cannabis ETF | $1.63M |
| DFISDimensional - International Small Cap ETF | $1.46M |
| DFICDimensional - International Core Equity 2 ETF | $1.42M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from CRON’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q3 earnings beat estimates with record revenue of $63M and share price gains, though net income declined; mostly positive earnings-driven coverage.